Introduction: To date scientists and religious leaders have not yet engaged in sustained face-to-face conversation concerning precision public health-related genetic technologies. Objectives: To elucidate areas of commonality and divergence in scientists’ and religious leaders’ views of precision genetic technologies, and extract lessons conveyed by religious leaders to scientists, and scientists to religious leaders through participatory dialogue. Methods: Six 1.5-h dialogue sessions were held between 6 religious leaders, 8 University of Michigan scientists, and 3 additional public health/genetic counseling graduate students between October 2016 and September 2017, followed by an open conference at the Ann Arbor Public Library (n = 46). Statements were organized into thematically arranged duets comparing views of scientists and religious leaders. Duets were further ordered into interpretive levels. Comparative techniques were used to assure category agreement and face validity. Results: The analysis yielded 20 duets and 3 interpretive levels (expositional; implications and consequences; and integrative, bridging concepts). Scientists emphasized the value of epigenetic testing for health promotion, and cost saving for some forms of early genetic testing for adult-onset conditions. Religious leaders stressed care for an individual’s willingness to change over technical fixes for behavioral conditions and, together with public participants, the importance of allocating money for societal needs. Both expressed caution on the use of nuclear transfer for mitochondrial DNA replacement and secondary uses of genetic data. Lay conference participants pointed towards a middle ground on the release of genetically edited mosquitoes for disease eradication. Discussion: Scientists stressed the value of professional guidance; religious leaders listened to family needs. Dialogues met four literature-based criteria for stakeholder involvement in deliberative processes. Conclusion: While scientists and religious leaders differ in their points of emphasis and faith orientations (professional competency versus drawing on compassion), they can successfully collaborate in reaching mutual understanding and specific areas of agreement on precision genetic technologies relating to public health.

1.
Horton
RH
,
Lucassen
AM
.
Recent developments in genetic/genomic medicine
.
Clin Sci (Lond)
.
2019
Mar
;
133
(
5
):
697
708
.
[PubMed]
0143-5221
2.
Molster
CM
,
Bowman
FL
,
Bilkey
GA
,
Cho
AS
,
Burns
BL
,
Nowak
KJ
, et al
The evolution of public health genomics: exploring its past, present, and future
.
Front Public Health
.
2018
Sep
;
6
:
247
.
[PubMed]
2296-2565
3.
Khoury
MJ
,
Bowen
MS
,
Clyne
M
,
Dotson
WD
,
Gwinn
ML
,
Green
RF
, et al
From public health genomics to precision public health: a 20-year journey
.
Genet Med
.
2018
Jun
;
20
(
6
):
574
82
.
[PubMed]
1098-3600
4.
Ginsburg
GS
,
Willard
HF
, editors
.
Genomic and Precision Medicine: Foundations, Translation, and Implementation
. 3rd ed.
Cambridge (MA)
:
Academic Press
;
2016
.
5.
Park
A
.
The next frontier in fertility treatments
.
Time
.
2019
;
193
:
34
7
.0040-781X
6.
Jameson
JL
,
Longo
DL
.
Precision medicine—personalized, problematic, and promising
.
N Engl J Med
.
2015
Jun
;
372
(
23
):
2229
34
.
[PubMed]
0028-4793
7.
Lowy
I
.
Imperfect Pregnancies: A History of Birth Defects
.
Baltimore (MD)
:
Johns Hopkins University Press
;
2017
.
8.
McKusick
VA
. The Human Genome Project: Plans, Status, and Applications in Biology and Medicine. In:
Annas
GJ
,
Elias
S
, editors
.
Gene Mapping: Using Law and Ethics as Guides
.
New York
:
Oxford University Press
;
1992
. pp.
18
42
.
9.
Annas
GJ
,
Elias
S
. The Major Social Policy Issues Raised by the Human Genome Project. In:
Annas
GJ
,
Elias
S
, editors
.
Gene Mapping: Using Law and Ethics as Guides
.
New York
:
Oxford University Press
;
1992
. pp.
3
17
.
10.
Glasgow
RE
,
Kwan
BM
,
Matlock
DD
.
Realizing the full potential of precision health: the need to include patient-reported health behavior, mental health, social determinants, and patient preferences data
.
J Clin Transl Sci
.
2018
Jun
;
2
(
3
):
183
5
.
[PubMed]
2059-8661
11.
Khoury
MJ
,
Gwinn
ML
,
Glasgow
RE
,
Kramer
BS
.
A population approach to precision medicine
.
Am J Prev Med
.
2012
Jun
;
42
(
6
):
639
45
.
[PubMed]
0749-3797
12.
Poulton
A
,
Lewis
S
,
Hui
L
,
Halliday
JL
.
Prenatal and preimplantation genetic diagnosis for single gene disorders: A population-based study from 1977 to 2016
.
Prenat Diagn
.
2018
Nov
;
38
(
12
):
904
10
.
[PubMed]
0197-3851
13.
Specter
M.
How the DNA revolution is changing us.
Natl Geo
2016
;230:31,36, 40, 41, 44, 46, 48, 49, 52, 55.
14.
Rothstein
MA
,
Cai
Y
,
Marchant
GE
.
The ghost in our genes: legal and ethical implications of epigenetics
.
Health Matrix Clevel
.
2009
;
19
(
1
):
1
62
.
[PubMed]
0748-383X
15.
Joseph
A
.
World’s first baby born with novel three parent embryo technique.
STATnews September 27,
2016
. https://www.statnews.com/2016/09/27/three-parent-baby-embryo (accessed October 19, 2016).
16.
Schaefer
GO
,
Emanuel
EJ
,
Wertheimer
A
.
The obligation to participate in biomedical research
.
JAMA
.
2009
Jul
;
302
(
1
):
67
72
.
[PubMed]
0098-7484
17.
De Vries
RG
,
Tomlinson
T
.
Americans want a say in what happens to their donated blood and tissue biobanks.
The Conversation July 13,
2016
. http://theconversation.com/americans-want-a-say-in-what-happens-to-their-donated-blood-and-tissue-in-biobanks-60681 (accessed November 14, 2016).
18.
Tomlinson
T
,
De Vries
R
,
Ryan
K
,
Kim
HM
,
Lehpamer
N
,
Kim
SY
.
Moral concerns and the willingness to donate to a research biobank
.
JAMA
.
2015
Jan
;
313
(
4
):
417
9
.
[PubMed]
0098-7484
19.
Hercher
L
,
Uhlmann
WR
,
Hoffman
EP
,
Gustafson
S
,
Chen
KM
;
Public Policy Committee of NSGC
.
the Public Policy Committee of NSGC. Prenatal testing for adult onset conditions: the position of the National Society of Genetic Counselors
.
J Genet Couns
.
2016
Dec
;
25
(
6
):
1139
45
.
[PubMed]
1059-7700
20.
Gold
A
,
S Appelbaum
P
.
The inclination to evil and the punishment of crime - from the bible to behavioral genetics
.
Isr J Psychiatry Relat Sci
.
2014
;
51
(
3
):
162
8
.
[PubMed]
2617-2402
21.
McSwiggan
S
,
Elger
B
,
Appelbaum
PS
.
The forensic use of behavioral genetics in criminal proceedings: case of the MAOA-L genotype
.
Int J Law Psychiatry
.
2017
Jan - Feb
;
50
:
17
23
.
[PubMed]
0160-2527
22.
Caspi
A
,
McClay
J
,
Moffitt
TE
,
Mill
J
,
Martin
J
,
Craig
IW
, et al
Role of genotype in the cycle of violence in maltreated children
.
Science
.
2002
Aug
;
297
(
5582
):
851
4
.
[PubMed]
0036-8075
23.
Peacocke
A
(
Clayton
P
, editor
).
All That Is: A Naturalistic Faith for the Twenty-First Century
.
Minneapolis (MN)
:
Fortress Press
;
2007
.
24.
Bartlett
VL
,
Johnson
RL
.
God and genes in the caring professions: clinician and clergy perceptions of religion and genetics
.
Am J Med Genet C Semin Med Genet
.
2009
Feb
;
151C
(
1
):
41
51
.
[PubMed]
1552-4868
25.
Modell
SM
,
Citrin
T
,
King
SB
,
Kardia
SL
.
The role of religious values in decisions about genetics and the public’s health
.
J Relig Health
.
2014
Jun
;
53
(
3
):
702
14
.
[PubMed]
0022-4197
26.
White
BP
,
Blatz
J
,
Joseph
ML
.
Elevating community authority in collective impact
.
Stanf Soc Innov Rev
.
2019
;
17
:
48
55
.1542-7099
27.
Canone
E
,
Spruit
L
.
Rhetoric and philosophical discourse in Giordano Bruno’s Italian dialogues
.
Poetics Today
.
2007
;
28
(
3
):
363
91
. 0333-5372
28.
Blume
M
.
Charles Darwin preferred dialogue.
The Evolution Institute March 5,
2012
. https://evolution-institute.org/evolution-and-religion-charles-darwin-preferred-dialogue (accessed August 16, 2017).
29.
Harris
TM
,
Parrott
R
,
Dorgan
KA
.
Talking about human genetics within religious frameworks
.
Health Commun
.
2004
;
16
(
1
):
105
16
.
[PubMed]
1041-0236
30.
White
MT
.
Making sense of genetic uncertainty: the role of religion and spirituality
.
Am J Med Genet C Semin Med Genet
.
2009
Feb
;
151C
(
1
):
68
76
.
[PubMed]
1552-4868
31.
Kalfoglou
AL
,
Doksum
T
,
Bernhardt
B
,
Geller
G
,
LeRoy
L
,
Mathews
DJ
, et al
Opinions about new reproductive genetic technologies: hopes and fears for our genetic future
.
Fertil Steril
.
2005
Jun
;
83
(
6
):
1612
21
.
[PubMed]
0015-0282
32.
Phan
KL
,
Doukas
DJ
,
Fetters
MD
.
Religious leaders’ attitudes and beliefs about genetics research and the Human Genome Project
.
J Clin Ethics
.
1995
;
6
(
3
):
237
46
.
[PubMed]
1046-7890
33.
Collins
FS
.
The Language of God
.
New York
:
Free Press
;
2006
.
34.
National Bioethics Advisory Commission (NBAC)
. “
Cloning Human Beings: Report and Recommendations of the National Bioethics Advisory Commission.
” Rockville, MD, NBAC, June
1997
, 39.
35.
National Bioethics Advisory Commission (NBAC)
. “
Ethical Issues in Human Stem Cell Research, Vol. 3 - Religious Perspectives.
” Rockville, MD, U.S. National Bioethics Advisory Commission, June
2000
.
36.
Yankelovich
D
.
The Magic of Dialogue
.
New York
:
Simon & Schuster
;
1999
.
37.
Modell
SM
.
Genetic and reproductive technologies in the light of religious dialogue
.
Zygon
.
2007
;
42
(
1
):
163
82
. 0591-2385
38.
Thiel
DB
,
Platt
T
,
Platt
J
,
King
SB
,
Kardia
SL
.
Community perspectives on public health biobanking: an analysis of community meetings on the Michigan BioTrust for Health
.
J Community Genet
.
2014
Apr
;
5
(
2
):
125
38
.
[PubMed]
1868-310X
39.
Bonham
VL
,
Citrin
T
,
Modell
SM
,
Franklin
TH
,
Bleicher
EW
,
Fleck
LM
.
Community-based dialogue: engaging communities of color in the United states’ genetics policy conversation
.
J Health Polit Policy Law
.
2009
Jun
;
34
(
3
):
325
59
.
[PubMed]
0361-6878
40.
Young
IM
. Communication and the Other: Beyond Deliberative Democracy. In:
Benhabib
S
, editor
.
Democracy and Difference
.
Princeton (NJ)
:
Princeton University Press
;
1996
. pp.
120
35
.
41.
Wallerstein
N
,
Duran
B
,
Oetzel
J
,
Minkler
M
.
Community-Based Participatory Research for Health: Advancing Social and Health Equity
. 3rd ed.
San Francisco (CA)
:
Jossey-Bass
;
2017
.
42.
Hacker
KA
.
Community-Based Participatory Research
.
Thousand Oaks (CA)
:
SAGE Publications
;
2013
.
43.
Minkler
M
,
Wallerstein
N
, editors
.
Community-Based Participatory Research for Health: From Process to Outcomes
. 2nd ed.
San Francisco
:
Jossey-Bass
;
2008
.
44.
Israel
BA
,
Eng
E
,
Schulz
AJ
,
Parker
EA
, editors
.
Methods in Community-Based Participatory Research for Health
.
San Francisco (CA)
:
Jossey-Bass
;
2005
.
45.
Campbell
MK
,
Hudson
MA
,
Resnicow
K
,
Blakeney
N
,
Paxton
A
,
Baskin
M
.
Church-based health promotion interventions: evidence and lessons learned
.
Annu Rev Public Health
.
2007
;
28
(
1
):
213
34
.
[PubMed]
0163-7525
46.
Langbo
C
,
Bach
J
,
Kleyn
M
,
Downes
FP
.
From newborn screening to population health research: implementation of the Michigan BioTrust for health
.
Public Health Rep
.
2013
Sep-Oct
;
128
(
5
):
377
84
.
[PubMed]
0033-3549
47.
O’Doherty
KC
,
Burgess
MM
.
Engaging the public on biobanks: outcomes of the BC biobank deliberation
.
Public Health Genomics
.
2009
;
12
(
4
):
203
15
.
[PubMed]
1662-4246
48.
Swede
H
,
Stone
CL
,
Norwood
AR
.
National population-based biobanks for genetic research
.
Genet Med
.
2007
Mar
;
9
(
3
):
141
9
.
[PubMed]
1098-3600
49.
Rotimi
C
,
Leppert
M
,
Matsuda
I
,
Zeng
C
,
Zhang
H
,
Adebamowo
C
, et al;
International HapMap Consortium
.
Community engagement and informed consent in the International HapMap project
.
Community Genet
.
2007
;
10
(
3
):
186
98
.
[PubMed]
1422-2833
50.
National Academies of Sciences, Engineering, and Medicine. International Summit on Human Gene Editing: A Global Discussion, December 1-3,
2015
, Washington, D.C. http://nationalacademies.org/gene-editing/Gene-Edit-Summit (accessed October 19, 2016).
51.
Thompson
C
.
CRISPR: move beyond differences
.
Nature
.
2015
Jun
;
522
(
7557
):
415
.
[PubMed]
0028-0836
52.
Etchegary
H
,
Wilson
B
.
Bringing personalized medicine to the community through public engagement
.
Per Med
.
2013
Sep
;
10
(
7
):
647
59
.
[PubMed]
1741-0541
53.
Modell
SM
,
Greendale
K
,
Citrin
T
,
Kardia
SL
.
Expert and advocacy group consensus findings on the horizon of public health genetic testing
.
Healthcare (Basel)
.
2016
Jan
;
4
(
1
):
E14
.
[PubMed]
2227-9032
54.
Wallerstein
N
,
Duran
B
,
Minkler
M
,
Foley
K
. Developing and Maintaining Partnerships with Communities. In:
Israel
BA
,
Eng
E
,
Schulz
AJ
,
Parker
EA
, editors
.
Methods in Community-Based Participatory Research for Health
.
San Francisco
:
Jossey-Bass
;
2005
. pp.
31
51
.
55.
Morgan
DL
.
Focus Groups as Qualitative Research
. 2nd ed.
Thousand Oaks (CA)
:
SAGE Publications
;
1997
.
56.
Krueger
RA
.
Focus Groups: A Practical Guide for Applied Research
. 2nd ed.
Thousand Oaks (CA)
:
SAGE Publications
;
1994
.
57.
Fleck
LM
.
Just Caring: Health Reform
.
New York
:
Oxford University Press
;
2006
.
58.
Gutmann
A
,
Thompson
D
.
Deliberating about bioethics
.
Hastings Cent Rep
.
1997
May-Jun
;
27
(
3
):
38
41
.
[PubMed]
0093-0334
59.
Becker
AB
,
Isreal
BA
,
Allen
AJ
 3rd
. “Strategies and Techniques in Effective Group Process in CBPR Partnerships.” In Methods in Community-Based Participatory Research for Health, eds. BA Israel, Eng, AJ Schulz, EA Parker. San Francisco, CA, Jossey-Bass,
2005
, 52-72.
60.
Krueger
RA
,
King
JA
.
Involving Community Members in Focus Groups
.
Thousand Oaks (CA)
:
SAGE Publications
;
1998
.
61.
Lemke
AA
,
Harris-Wai
JN
.
Stakeholder engagement in policy development: challenges and opportunities for human genomics
.
Genet Med
.
2015
Dec
;
17
(
12
):
949
57
.
[PubMed]
1098-3600
62.
Morgan
DL
,
Fellows
C
,
Guevara
H
. Emergent Approaches to Focus Group Research. In:
Hesse-Biber
SN
,
Leavy
P
, editors
.
Handbook of Emergent Methods
.
New York
:
Guilford Press
;
2007
. pp.
189
206
.
63.
Law
PM
,
Basole
RC
,
Wu
Y
.
Duet: helping data analysis novices conduct pairwise comparisons by minimal specification
.
IEEE Trans Vis Comput Graph
.
2018
Aug
;
25
(
1
):
427
37
.
[PubMed]
1077-2626
64.
Krejci-Papa
M
.
Soulful reasoning.
Science & Spirit
2007
. https://www.questia.com/magazine/1G1-171141275/soulful-reasoning-when-it-comes-to-ethical-issues (accessed January 5, 2019).
65.
Rothenberg
KH
,
Rutkin
AB
.
Toward a framework of mutualism: the Jewish community in genetics research
.
Community Genet
.
1998
;
1
(
3
):
148
53
.
[PubMed]
1422-2795
66.
Children’s Hospital of Philadelphia
.
Von Hippel-Lindau syndrome.
https://www.chop.edu/conditions-diseases/von-hippel-lindau-syndrome (accessed July 8, 2018).
67.
Klitzman
R
.
The Ethics Police: The Struggle to Make Human Research Safe
.
New York
:
Oxford University Press
;
2015
.
68.
Chrysler
D
,
McGee
H
,
Bach
J
,
Goldman
E
,
Jacobson
PD
.
The Michigan BioTrust for Health: using dried bloodspots for research to benefit the community while respecting the individual
.
J Law Med Ethics
.
2011
Mar
;
39
(
1_suppl
Suppl 1
):
98
101
.
[PubMed]
1073-1105
69.
Iowa Department of Public Health
.
Iowa Maternal Prenatal Screening Program.
https://idph.iowa.gov/public/maternal-prenatal-screening (accessed June 19, 2019).
70.
Maryland Department of Health
.
AFP Testing for Improved Pregnancy Outcome.
https://phpa.health.maryland.gov/genetics/Pages/afp_tst.aspx (accessed June 19, 2019).
71.
California Department of Public Health
.
The California Prenatal Screening Program.
https://www.cdph.ca.gov/Programs/CFH/DGDS/Pages/pns/patientinformation.aspx# (accessed June 19, 2019).
72.
Sagi
M
,
Weinberg
N
,
Eilat
A
,
Aizenman
E
,
Werner
M
,
Girsh
E
, et al
Preimplantation genetic diagnosis for BRCA1/2—a novel clinical experience
.
Prenat Diagn
.
2009
May
;
29
(
5
):
508
13
.
[PubMed]
0197-3851
73.
Bennett
J
,
Chitty
L
,
Lewis
C
.
Non-invasive prenatal diagnosis for BRCA mutations – A qualitative pilot study of health professionals’ views
.
J Genet Couns
.
2016
Feb
;
25
(
1
):
198
207
.
[PubMed]
1059-7700
74.
Daum
H
,
Peretz
T
,
Laufer
N
.
BRCA mutations and reproduction
.
Fertil Steril
.
2018
Jan
;
109
(
1
):
33
8
.
[PubMed]
0015-0282
75.
Mor
P
,
Brennenstuhl
S
,
Metcalfe
KA
.
Uptake of preimplantation genetic diagnosis in female BRCA1 and BRCA2 mutation carriers
.
J Genet Couns
.
2018
Dec
;
27
(
6
):
1386
94
.
[PubMed]
1059-7700
76.
Hayward
J
,
Chitty
LS
.
Beyond screening for chromosomal abnormalities: advances in non-invasive diagnosis of single gene disorders and fetal exome sequencing
.
Semin Fetal Neonatal Med
.
2018
Apr
;
23
(
2
):
94
101
.
[PubMed]
1744-165X
77.
Knoppers
BM
,
Sénécal
K
,
Borry
P
,
Avard
D
.
Whole-genome sequencing in newborn screening programs
.
Sci Transl Med
.
2014
Mar
;
6
(
229
):
229cm2
.
[PubMed]
1946-6234
78.
California Department of Health
.
California Biobank Program.
https://www.cdph.ca.gov/Programs/CFH/DGDS/Pages/cbp/default.aspx (accessed June 19, 2019).
79.
Matthis
S
. Mosquito: Oxitec is courting the keys again. Florida Keys Weekly February 20,
2018
. https://keysweekly.com/42/mosquito-oxitec-is-courting-the-keys-again (accessed July 8, 2018).
80.
Anderson
RR
.
Religious traditions and prenatal genetic counseling
.
Am J Med Genet C Semin Med Genet
.
2009
Feb
;
151C
(
1
):
52
61
.
[PubMed]
1552-4868
81.
Nelson
JR
.
On the New Frontiers of Genetics and Religion
.
Grand Rapids (MI)
:
William B. Eerdmans Publishing Company
;
1994
.
82.
Mello
MM
,
Wolf
LE
.
The Havasupai Indian tribe case—lessons for research involving stored biologic samples
.
N Engl J Med
.
2010
Jul
;
363
(
3
):
204
7
.
[PubMed]
0028-4793
83.
Burton
H
,
Adams
M
,
Bunton
R
,
Schröder-Bäck
P
.
Developing stakeholder involvement for introducing public health genomics into public policy
.
Public Health Genomics
.
2009
;
12
(
1
):
11
9
.
[PubMed]
1662-4246
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.